Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy

Keyphrases

• Anticancer Agents 33%
• Catechol 100%
• Cisplatin 66%
• Complete Cure 33%
• Controlled Release 33%
• Coordination Chemistry 33%
• Coordination Polymer Nanoparticles 100%
• Cytotoxicity 33%
• Engineered Nanoparticles 33%
• GL261 33%
• GL261 Cells 33%
• Glioblastoma 33%
• Glioblastoma multiforme 33%
• Glioblastoma Therapy 100%
• HeLa Cells 33%
• Imaging Follow-up 33%
• Intranasal 33%
• Intranasal Administration 100%
• Iron Ion 33%
• Magnetic Resonance 33%
• Novel Therapies 33%
• PH-sensitive 33%
• Platinum(IV) Prodrugs 33%
• Prolonged Survival 33%
• Pt(IV) 100%
• Redox Sensitivity 33%
• Rescue Treatment 33%
• Second-line Treatment 33%
• Tumor 33%
• Tumor-bearing Mice 33%

Medicine and Dentistry

• Anticarcinogen 20%
• Cisplatin 40%
• Controlled Release 20%
• Cytotoxicity 20%
• Glioblastoma 100%
• In Vitro 20%
• Intranasal Drug Administration 100%
• Magnetic Resonance Imaging 20%
• Metal Ion 20%
• Nanoparticle 100%
• Neoplasm 40%
• Prodrug 20%
• Side Effect 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticarcinogen 20%
• Catechol 100%
• Cisplatin 40%
• Controlled Release 20%
• Cytotoxicity 20%
• Glioblastoma 100%
• Metal Ion 20%
• Nanoparticle 100%
• Neoplasm 40%
• Prodrug 20%
• Side Effect 20%